Clinical Trials

Clinical Trials

Please contact the Cancer Research Nurse at (907) 264-2933 with questions regarding open clinical trials at Alaska Regional Hospital.

  • Molecular Targets – A new series of clinical trials, Novartis SIGNATURE is recruiting patients with different cancers to receive investigational targeted drugs selected to match the distinct genetic changes found in each patient’s tumor.

Brain

Currently No Open Clinical Trials

Breast

  • (Adjuvant Stage I - III): SWOG 1007 - A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone-responsive and Her2-Negative Breast Cancer according to Recurrence Score (RS).
  • (Prevention): SWOG 0812 - Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer.
  • (Prevention of Recurrence): SWOG 0820 - A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancer in Patients with Stage 0-111 Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES).

Gastrointestinal

Genitourinary

Currently No Open Clinical Trials

Gynecology

Currently No Open Clinical Trials

Head & Neck

Currently No Open Clinical Trials

Lung

  • (Non-Small Cell Lung Cancer - NSCLC): AMGEN - A randomized, double-blind, placebo-controlled study to evaluate the long-term safety and efficacy of Darbepoetin Afla administered every 3 weeks in anemic subjects with advanced stage non-small cell lung cancer receiving multi-cycle chemotherapy.
  • (Non-Small Cell Lung Cancer - NSCLC): SWOG 0819 - A Randomized, Phase III Study of Comparing Carboplatin / Paclitaxel or Carboplatin / Paclitaxel / Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).
    • (Non-Hodgkin's)

 

Currently No Open Clinical Trials

    • (Hodgkin's)

 

Currently No Open Clinical Trials

    • (Mantle Cell)

 

Currently No Open Clinical Trials

Lymphoma

Miscellaneous

Currently No Open Clinical Trials

Melanoma

  • CTSU/ECOG 1609 - A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alpha-2b for Resected High-Risk Melanoma.

Myeloma

Currently No Open Clinical Trials